Skip to main content

Health-Related Quality of Life and Urolithiasis

  • Chapter
  • First Online:
Book cover Nutrition Therapy for Urolithiasis

Abstract

Symptomatic urinary stone disease mandates treatment to help patients. Stone-free status has been the principle measure of success to determine how well stone formers have been treated. Although stone elimination remains paramount, success outcomes, as in other disease processes, will begin to include the patient’s perception of treatment and hopeful prevention of further disease. Health-related quality of life (HRQoL) addresses more than simple assessments of desired endpoints, such as stone-free status, or physical symptoms, such as pain. Measuring HRQOL includes assessing domains related to physical, mental, emotional, and social functioning in order to evaluate the impact health status has on patient perception of quality of life.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 79.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 99.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 129.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Tefekli A, Cezayirli F. The history of urinary stones: in parallel with civilization. Sci World J. 2013;2013:1–5. doi:10.1155/2013/423964.

    Google Scholar 

  2. Pearle M, Calhoun E, Curhan G. Urologic diseases in America project: urolithiasis. J Urol. 2005;173:848–57. doi:10.1097/01.ju.0000152082.14384.d7.

    Article  PubMed  Google Scholar 

  3. Saigal CS, Joyce G, Timilsina AR. Direct and indirect costs of nephrolithiasis in an employed population: opportunity for disease management? Kidney Int Kidney Int. 2005;68:1808–14. doi:10.1111/j.1523-1755.2005.00599.x.

    Article  PubMed  Google Scholar 

  4. Scales CD, Smith AC, Hanley JM, Saigal CS. Prevalence of kidney stones in the United States. Eur Urol. 2012;62(1):160–5. doi:10.1016/j.eururo.2012.03.052.

    Article  PubMed  PubMed Central  Google Scholar 

  5. Penniston KL, Nakada SY. Health related quality of life differs between male and female stone formers. J Urol. 2007;178:2435–40.

    Article  PubMed  Google Scholar 

  6. Moe OW. Kidney stones: pathophysiology and medical management. Lancet. 2006;367:333–44.

    Article  CAS  PubMed  Google Scholar 

  7. Stamatelou KK, Francis ME, Jones CA, Nyberg LM, Curhan GC. Time trends in reported prevalence of kidney stones in the United States: 1976–19941. Kidney Int Kidney Int. 2003;63:1817–23. doi:10.1046/j.1523-1755.2003.00917.x.

    Article  PubMed  Google Scholar 

  8. Worcester EM, Coe FL. Nephrolithiasis. Prim Care. 2008;35:369–91. doi:10.1016/j.pop.2008.01.005.

    Article  PubMed  PubMed Central  Google Scholar 

  9. Pearle MS, Roehrborn CG, Pak CY. Meta-analysis of randomized trials for medical prevention of calcium oxalate nephrolithiasis. J Endourol. 1999;13(9):679–85. doi:10.1089/end.1999.13.679.

    Article  CAS  PubMed  Google Scholar 

  10. Xu H, Zisman AL, Coe FL, Worcester EM. Kidney stones: an update on current pharmacological management and future directions. Expert Opin Pharmacother Expert Opin Pharmacother. 2013;14(4):435–47. doi:10.1517/14656566.2013.775250.

    Article  CAS  PubMed  Google Scholar 

  11. Frassetto L, Kohlstadt I. Treatment and Prevention of kidney stones: an update [Internet]. AAFP Am Acad Fam Phys. 2011. Cited 15 Jun 2015. Retrieved from: http://www.aafp.org/afp/2011/1201/p1234.html.

  12. Milicevic S, Bijelic R, Krivokuca V, Bojic M, Popovicpejicic S, Bojanic N. Correlation of the body mass index and calcium nephrolithiasis in adult population. Med Arch Med Arh. 2013;67(6):423. doi:10.5455/medarh.2013.67.423-427.

    Article  Google Scholar 

  13. McAninch JW, Lue TF, Smith DR. Chapter 17/urinary stone disease. Smith and Tanagho’s general urology. In: McAninch JW, Lue TF, editors. S&T urology. 18th ed. New York: McGraw-Hill Professional; 2013. p. 249–79.

    Google Scholar 

  14. Leavitt DA, de la Rosette J, et al. Chapter 53. Campbell-Wash Urology. 11th ed. Elsevier; 2016. p. 1235–59.

    Google Scholar 

  15. Preminger GM, Tiselius H-G, Assimos DG, Alken P, Buck C, Gallucci M, et al. Guideline for the management of ureteral calculi. J Urol. 2007. 2007;178(6):2418–34. doi:10.1016/j.juro.2007.09.107.

    Article  PubMed  Google Scholar 

  16. Nuttall MC, Abbaraju J, Dickinson IK, Sriprasad S. A review of studies reporting on complications of upper urinary tract stone ablation using the holmium:YAG laser. Br J Med Surg Urol. 2010;3(4):151–9. doi:10.1016/j.bjmsu.2010.01.008.

    Article  Google Scholar 

  17. Bader MJ, Eisner B, Porpiglia F, Preminger GM, Tiselius H-G. Contemporary management of ureteral stones. Eur Urol. 2012;61(4):764–72. doi:10.1016/j.eururo.2012.01.009.

    Article  PubMed  Google Scholar 

  18. Borghi L, Meschi T, Amato F, Giannini A, Quarantelli C, Mineo F. Nifedipine and methylprednisolone in facilitating ureteral stone passage: a randomized, double-blind, placebo-controlled study. J Urol. 1994;152:1095–8.

    Article  CAS  PubMed  Google Scholar 

  19. Qaseem A, Dallas P, Forciea MA, Starkey M, Denberg TD. For the clinical guidelines committee of the American College of Physicians. Dietary and pharmacologic management to prevent recurrent nephrolithiasis in adults: a clinical practice guideline from the American College of Physicians. Ann Intern Med. 2014;161:659–67. doi:10.7326/M13-2908.

    Article  PubMed  Google Scholar 

  20. Taylor EN. Obesity, weight gain, and the risk of kidney stones. JAMA. 2005;293(4):455. doi:10.1001/jama.293.4.455.

    Article  CAS  PubMed  Google Scholar 

  21. Ortiz-Alvarado O, Miyaoka R, Kriedberg C, Moeding A, Stessman M, Anderson JK, et al. Impact of dietary counseling on urinary stone risk parameters in recurrent stone formers. J Endourol. 2011;25(3):535–40. doi:10.1089/end.2010.0241.

    Article  PubMed  Google Scholar 

  22. Borghi L, Schianchi T, Meschi T, Guerra A, Allegri F, Maggiore U, et al. Comparison of two diets for the prevention of recurrent stones in idiopathic hypercalciuria. N Engl J Med N Engl J Med. 2002;346(2):77–84. doi:10.1056/nejmoa010369.

    Article  CAS  PubMed  Google Scholar 

  23. Litwin MS, Nied RJ, Dhanani N. Health-related quality of life in men with erectile dysfunction. J Gen Intern Med J Gen Intern Med. 1998;13(3):159–66. doi:10.1046/j.1525-1497.1998.00050.x.

    Article  CAS  PubMed  Google Scholar 

  24. Ware JE, Sherbourne CD. The MOS 36-ltem short-form health survey (SF-36). Med Care. 1992;30(6):473–83. doi:10.1097/00005650-199206000-00002.

    Article  PubMed  Google Scholar 

  25. Deiner E, Emmons RA, Larsen RJ, Griffin S. The satisfaction with life scale. J Pers Assess. 1985;49:71–5.

    Article  Google Scholar 

  26. Patrick DL, Deyo RA. Generic and disease-specific measures in assessing health sand quality of life. Med Care. 1989;27(Supplement):S217. doi:10.1097/00005650-198903001-00018.

    Article  CAS  PubMed  Google Scholar 

  27. Mchorney CA, Johne W, Anastasiae R. The MOS 36-item short-form health survey (SF-36). Med Care. 1993;31(3):247–63. doi:10.1097/00005650-199303000-00006.

    Article  CAS  PubMed  Google Scholar 

  28. Breslin S. Quality of life: how is it measured and defined? Urol Int Urol Int. 1991;46(3):246–51. doi:10.1159/000282146.

    Article  CAS  PubMed  Google Scholar 

  29. Esper P, Mo F, Chodak G, Sinner M, Cella D, Pienta KJ. Measuring quality of life in men with prostate cancer using the functional assessment of cancer therapy-prostate instrument. Urology. 1997;50(6):920–8. doi:10.1016/s0090-4295(97)00459-7.

    Article  CAS  PubMed  Google Scholar 

  30. Barry MJ, Fowler FJ, O'leary MP, Bruskewitz RC, Holtgrewe HL, Mebust WK, et al. The American Urological Association symptom index for benign prostatic hyperplasia. The measurement Committee of the American Urological Association. J Urol. [Internet. 1992. [cited 2015Aug8;148(5):1549–57. Retrieved from: http://www-ncbi-nlm-nih-gov.ezproxy.uthsc.edu/pubmed/?term=the+american+urological+association+symptom+index+for+benign+prostatic+hyperplasia.+the+measurement+committee+of+the+american+urological+association

  31. Mays NB, Petruckevitch A, Snowdon C. Patients’ quality of life following extracorporeal shock-wave lithotripsy and percutaneous nephrolithotomy for renal calculi. Int J Technol Assess Health Care J of Inter Technol of Health Care. 1990;6(04):633. doi:10.1017/s026646230000427x.

    Article  CAS  Google Scholar 

  32. Deem S, Defade B, Modak A, Emmett M, Martinez F, Davalos J. Percutaneous nephrolithotomy versus extracorporeal shock wave lithotripsy for moderate sized kidney stones. Urology. 2011;78(4):739–43. doi:10.1016/j.urology.2011.04.010.

    Article  PubMed  Google Scholar 

  33. Arafa MA, Rabah DM. Study of quality of life and its determinants in patients after urinary stone fragmentation. Health Qual Life Outcomes. 2010;8(1):119. doi:10.1186/1477-7525-8-119.

    Article  PubMed  PubMed Central  Google Scholar 

  34. Bergman J, Gore JL, Singer JS, Anger JT, Litwin MS. Readability of health related quality of life instruments in urology. J Urol. 2010;183(5):1977–81. doi:10.1016/j.juro.2009.12.107.

    Article  PubMed  Google Scholar 

  35. Donnally CJ, Gupta A, Bensalah K, Tuncel A, Raman J, Pearle MS, et al. Longitudinal evaluation of the SF-36 quality of life questionnaire in patients with kidney stones. Urol Res Urol Res. 2010;39(2):141. doi:10.1007/s00240-010-0313-2.

    Article  PubMed  Google Scholar 

  36. Penniston KL, Nakada SY. Development of an instrument to assess the health related quality of life of kidney stone formers. J Urol. 2013;189(3):921–30. doi:10.1016/j.juro.2012.08.247.

    Article  PubMed  Google Scholar 

  37. Penniston KL, Davis VP, et al. The Wisconsin stone quality of life questionnaire: baseline results from a prospective, longitudinal, multi-center validation study. J Urol. 2015;193(4):e304–5.

    Article  Google Scholar 

  38. Rabah DM, Alomar M, Binsaleh S, Arafa MA. Health related quality of life in ureteral stone patients: post-ureterolithiasis. Urol Res Urol Res. 2011;39(5):385–8. doi:10.1007/s00240-011-0375-9.

    Article  PubMed  Google Scholar 

  39. Diniz DH, Blay SL, Schor N. Quality of life of patients with nephrolithiasis and recurrent painful renal colic. Nephron Clin Pract Nephron Clin Pract. 2007;106(3):c91–7. doi:10.1159/000102995.

    Article  PubMed  Google Scholar 

  40. Parr JM, Desai D, Winkle D. Natural history and quality of life in patients with cystine urolithiasis: a single centre study. BJU Int BJU Int. 2015; doi:10.1111/bju.13169.

  41. Bensalah K, Tuncel A, Gupta A, Pearle MS, Lotan Y. Determinants of quality of life in patients with kidney stones. J Urol. 2008;179(4):166. doi:10.1016/s0022-5347(08)60479-6.

    Article  Google Scholar 

  42. Bryant M, Angell J, Tu H, Goodman M, Pattaras J, Ogan K. Health related quality of life for stone formers. J Urol. 2012;188(2):436–40. doi:10.1016/j.juro.2012.04.015.

    Article  PubMed  Google Scholar 

  43. Sahin C, Tuncer M, Yazıcı O, Horuz R, Çetinel AC, Eryıldırım B, et al. Do the residual fragments after shock wave lithotripsy affect the quality of life? Urology. 2014;84(3):549–54. doi:10.1016/j.urology.2014.05.012.

    Article  PubMed  Google Scholar 

  44. Kuo RL, Aslan P, Abrahamse PH, Matchar DB, Preminger GM. Incorporation of patient preferences in the treatment of upper urinary tract calculi: a decision analytical view. J Urol. 1999;162(6):1913–9. doi:10.1016/s0022-5347(05)68067-6.

    Article  CAS  PubMed  Google Scholar 

  45. Kurahashi T, Miyake H, Shinozaki M, Oka N, Takenaka A, Hara I, et al. Health-related quality of life in patients undergoing lithotripsy for urinary stones. Int Urol Nephrol Int Urol Nephrol. 2007;40(1):39–43. doi:10.1007/s11255-007-9231-9.

    Article  PubMed  Google Scholar 

  46. Staios D, Andrews HO, Shaik T, Buchholz NN. Quality of life after percutaneous nephrolithotomy for caliceal diverticulum and secluded lower-pole renal stones. J Endourol. 2007;21(5):515–9. doi:10.1089/end.2006.0432.

    Article  PubMed  Google Scholar 

  47. Chandrasekar T, Monga M, Nguyen M, Low RK. Internet-based patient survey on urolithiasis treatment and patient satisfaction. J Endourol. 2015;29(6):725–9. doi:10.1089/end.2014.0643.

    Article  PubMed  Google Scholar 

  48. Penniston KL, Sninsky BC, Nakada SY. Preliminary evidence of decreased disease-specific health related quality of life in asymptomatic stone formers. J Endourol. 2016;30(supp1):S42–5.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Patrick Lowry MD .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer International Publishing AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Sharadin, C., Lowry, P. (2018). Health-Related Quality of Life and Urolithiasis. In: Lowry, P., Penniston, K. (eds) Nutrition Therapy for Urolithiasis. Springer, Cham. https://doi.org/10.1007/978-3-319-16414-4_2

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-16414-4_2

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-16413-7

  • Online ISBN: 978-3-319-16414-4

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics